Taevas
SingaporeMedical Devices
Legal Representation
Legal Representation for Medical Devices in Singapore
Foreign medical devices manufacturers entering Singapore must appoint a local Authorised Representative under HSA regulations. Taevas Global provides compliant, experienced Legal Representation so your products reach the Singapore market without regulator
Market
Singapore
Industry
Medical Devices
Service
Legal Representation
Regulator
Health Sciences Authority (HSA)
Timeline
4-8 weeks to first registration submission
What We Deliver
Six Pillars of Singapore Medical Devices Intelligence
Our Legal Representation service for Medical Devices in Singapore is built on six interconnected pillars that cover every regulatory, commercial, and operational dimension of your market entry.
01
HSA Authorised Representative Services
Taevas Global acts as your Singapore-based Authorised Representative as required under the Health Products Act and HSA's Medical Devices Branch. We accept legal and regulatory responsibility on your behalf, enabling you to register products without a local corporate entity. Our team maintains active communication with HSA on all correspondence related to your device listings.
Appointment as Authorised Representative under the Health Products Act
Management of all HSA correspondence and regulatory queries
Maintenance of Singapore Device Registration (SDR) records
How It Works
From Brief to Board-Ready Intelligence
Our four-step engagement takes you from initial scoping through to active HSA registration management, with clear milestones and dedicated regulatory support at every stage.
Step 1 · Day 1-2
Scope and Regulatory Assessment
We conduct an initial consultation to understand your device portfolio, intended indications, and current regulatory status in other markets. Our team maps each product to the relevant HSA risk class and identifies any pre-submission queries or safety assessments required. You receive a clear scope document outlining timelines, fees, and required documentation.
Taevas Approach
This step includes a review of existing technical documentation such as CE marking files, FDA 510(k) clearances, or ISO 13485 certificates that can be leveraged to streamline the Singapore submission. We identify gaps early so there are no surprises during formal review.
Market Snapshot
Singapore Medical Devices Market at a Glance
S$0B+
Medical Devices Market Size (2023 est.)
0%
Projected Annual Market Growth Rate
0+
Active Device Registrations on HSA PRISM
0+
Global MedTech Manufacturers with Singapore HQ
Asia-Pacific Manufacturing Hub
Singapore hosts manufacturing facilities for more than 40 of the world's leading medical device companies, including major operations in diagnostics, cardiovascular devices, and advanced wound care. The Economic Development Board actively supports MedTech investments through grants and infrastructure. This concentration makes Singapore both a production base and a reference market for the broader ASEAN region.
HSA Risk-Based Regulatory Framework
The Health Sciences Authority regulates medical devices under the Health Products Act using a four-class risk-based system aligned with the ASEAN Medical Device Directive. Singapore was among the first ASEAN nations to implement this harmonised framework, giving registered products a credibility advantage in neighbouring markets. HSA's regulatory standards are internationally benchmarked and recognised by regulators in Australia, Canada, and the European Union.
Strong Public and Private Healthcare Demand
Singapore's healthcare system combines a highly developed public hospital network with a thriving private sector, creating sustained demand for advanced diagnostic, therapeutic, and monitoring devices. Government initiatives such as Healthier SG and the national digital health strategy are driving procurement of connected and AI-enabled medical devices. This demand profile favours innovative foreign manufacturers with differentiated technology.
Digital Health and MedTech Innovation Ecosystem
Singapore's Smart Nation initiative and the Ministry of Health's National Health Innovation Centre support the adoption of digital health technologies, wearables, and Software as a Medical Device (SaMD). HSA has published specific guidance on AI and machine learning-based medical devices, positioning Singapore as a forward-looking regulator. Companies with digital health portfolios find Singapore an ideal first-mover market in Southeast Asia.
What's Included
Everything in Your Engagement
Our Legal Representation service for Medical Devices in Singapore delivers a complete package of regulatory, legal, and commercial outputs designed to get your products registered and keep them compliant.
Authorised Representative Appointment Letter
A formal HSA-compliant appointment letter designating Taevas Global as your Singapore Authorised Representative, ready for inclusion in all registration submissions.
Regulatory Assessment Report
A written assessment of each device's HSA risk classification, applicable submission pathway, and a gap analysis of your existing technical documentation against Singapore requirements.
Technical Dossier Preparation
Complete preparation of the Technical Dossier in HSA-required format, including clinical evidence summary, risk management file reference, and labelling compliance review.
Authorised Representative Agreement
A legally binding agreement between your organisation and Taevas Global that defines responsibilities, indemnities, and operational procedures in compliance with HSA requirements.
MEDICS Portal Submission Management
End-to-end management of your application submissions through HSA's MEDICS online portal, including account setup, document upload, fee payment coordination, and query response.
Importer and Dealer Compliance Verification
Identification and verification of HSA-licensed importers or dealers in your supply chain, ensuring your distribution network meets all regulatory requirements before product launch.
Post-Market Surveillance Support
Ongoing management of post-market obligations including adverse event reporting, Field Safety Corrective Action notifications, and periodic safety update coordination with HSA.
Annual Compliance Review and Renewal Management
A structured annual review of all active device registrations covering renewal deadlines, label change requirements, and any new HSA guidance affecting your registered products.
Who This Is For
Built for These Situations
First-Time Market Entry
Foreign Manufacturer Entering Singapore for the First Time
You have CE-marked or FDA-cleared devices and want to access Singapore and the broader ASEAN market but have no local entity or regulatory presence. HSA requires a Singapore-based Authorised Representative before any registration can be submitted. Without one, your products cannot legally be placed on the Singapore market regardless of their approval status elsewhere.
Outcome
Achieve compliant HSA registration without establishing a local company, with a clear pathway to ASEAN market expansion.
Next Steps
After Legal Representation, Most Clients Move To
FAQ
Common Questions
Get Started
Ready to Map Your Singapore Opportunity?
Appoint Taevas Global as your Singapore Authorised Representative and bring your medical devices to one of Asia's most advanced and strategically important healthcare markets. Our regulatory specialists are ready to assess your portfolio and begin the HSA registration process.
HSA-compliant Authorised Representative appointment within days
End-to-end registration management for all device classes
Ongoing post-market compliance and renewal support
Gateway to broader ASEAN market access from Singapore